Chronic lymphocytic leukemia is a B-lymphocyte derived clonal malignant disorder. Presently available chemotherapy is only palliative and is withheld unless typical symptoms evolve. Newly developed cytostatic drugs such as Fludarabine, Pentostatin and 2-Chlorodeoxyadenosin have shown promising activity in cases otherwise resistant to conventional chemotherapy. Allogeneic bone marrow transplantation has been successfully applied in some younger patients. Bone marrow transplantation at this time represents the only curative therapeutic modality and should be considered in younger patients having a suitable donor.
机构:
BOSTON UNIV, MED CTR, EVANS MEM DEPT CLIN RES, MED ONCOL SECT, BOSTON, MA 02118 USABOSTON UNIV, MED CTR, EVANS MEM DEPT CLIN RES, MED ONCOL SECT, BOSTON, MA 02118 USA
CAGUIOA, PB
TANSAN, S
论文数: 0引用数: 0
h-index: 0
机构:
BOSTON UNIV, MED CTR, EVANS MEM DEPT CLIN RES, MED ONCOL SECT, BOSTON, MA 02118 USABOSTON UNIV, MED CTR, EVANS MEM DEPT CLIN RES, MED ONCOL SECT, BOSTON, MA 02118 USA
TANSAN, S
MCCAFFREY, RP
论文数: 0引用数: 0
h-index: 0
机构:
BOSTON UNIV, MED CTR, EVANS MEM DEPT CLIN RES, MED ONCOL SECT, BOSTON, MA 02118 USABOSTON UNIV, MED CTR, EVANS MEM DEPT CLIN RES, MED ONCOL SECT, BOSTON, MA 02118 USA
MCCAFFREY, RP
AMERICAN JOURNAL OF THE MEDICAL SCIENCES,
1994,
308
(03):
: 196
-
200